XCHO Financials 07/16/2014 17:13:42 XenaCare Hold
Post# of 3
Posted On: 07/16/2014 6:13:38 PM
XCHO Financials 07/16/2014 17:13:42
XenaCare Holdings, Inc.
Period Ending Dec 31, 2010
Total Revenue 1,983
Cost of Revenue 870
Gross Profit 1,113
Operating Expenses
Research and Development -
Sales, General and Admin. 3,584
Non-Recurring Items 637
Other -
Operating Income (3,108)
Income From Continuing Operations
Add'l Income/Expense Items (
Earnings Before Interest and Tax (3,115)
Interest Expense 273
Earnings Before Tax (3,388)
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (3,388)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (3,388)
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders (3,388)
XenaCare Holdings, Inc.
Period Ending Dec 31, 2010
Total Revenue 1,983
Cost of Revenue 870
Gross Profit 1,113
Operating Expenses
Research and Development -
Sales, General and Admin. 3,584
Non-Recurring Items 637
Other -
Operating Income (3,108)
Income From Continuing Operations
Add'l Income/Expense Items (
Earnings Before Interest and Tax (3,115)
Interest Expense 273
Earnings Before Tax (3,388)
Income Tax -
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations (3,388)
Non Recurring Events
Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income (3,388)
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders (3,388)
(0)
(0)Xenacare Holdings (XCHO) Stock Research Links
Scroll down for more posts ▼